New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Merck & Co., Inc.

MRK

Healthcare Drug Manufacturers General

Merck & Co., Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.0 billion, up 1.31% from fiscal 2024.

Revenue
+4.68%
EPS
−12.1%
Free cash flow
−19.3%
Total debt
+24.3%

Quarter to September 2026, against a year earlier

134.93 2.19 +1.65%
Market cap
$328.6B
P/E
137×
Fwd P/E FY26e
105×
Dividend yield
2.56%
F-score
4/9
ROIC
4.56%
Net debt / EBITDA
1.2×
Payout ratio
3.5×

Revenue to profit Fiscal 2025, year to Dec 31, 2025

Of every $100 of revenue, $28.09 was left as profit. What is an income statement?

Revenue to profit, in billions of dollars and as a share of revenue
Revenue65.0100.0%
Cost of revenue−16.4−25.2%
Gross profit48.674.8%
Research & development−15.8−24.3%
Selling, general & admin−10.7−16.5%
Operating income22.134.0%
Other income, net−1.0−1.6%
Income tax−2.8−4.3%
Net income18.328.1%
RevenueOperating incomeNet incomeNet margin (right axis)
Revenue, operating income and net income, ten years
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Revenue$39.8B$40.1B$42.3B$39.1B$41.5B$48.7B$59.3B$60.1B$64.2B$65.0B
Operating income$5.5B$6.8B$8.9B$7.9B$5.5B$13.2B$18.3B$3.0B$20.2B$22.1B
Net income$3.9B$2.4B$6.2B$5.6B$4.5B$12.4B$14.5B$377M$17.1B$18.3B
Net margin (right axis)9.9%6.0%14.6%14.3%10.9%25.4%24.5%0.6%26.7%28.1%
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue
65,011.00 64,168.00 60,115.00 59,283.00 48,704.00 41,518.00 39,121.00 42,294.00 40,122.00 39,807.00
Revenue Growth
1.31% 6.74% 1.40% 21.72% 17.31% 6.13% (7.50%) 5.41% 0.79% 0.78%
Gross Profit
48,629.00 48,975.00 43,989.00 41,872.00 35,078.00 27,900.00 27,105.00 28,785.00 27,210.00 25,777.00
Operating Income
22,107.00 20,221.00 2,954.00 18,282.00 13,199.00 5,548.00 7,926.00 8,931.00 6,797.00 5,499.00
EBT
21,067.00 19,936.00 1,889.00 16,444.00 13,879.00 5,863.00 7,171.00 8,701.00 6,521.00 4,659.00
Income after Tax
18,263.00 17,133.00 377.00 14,526.00 12,358.00 4,523.00 5,606.00 6,193.00 2,418.00 3,941.00
Net Income Common
18,254.00 17,117.00 365.00 14,519.00 13,049.00 7,067.00 9,843.00 6,220.00 2,394.00 3,920.00
EPS (Diluted)
7.28 6.74 0.14 5.71 5.14 2.78 3.81 2.32 0.93 1.41
Shares (Diluted, Weighted)
2,507.00 2,541.00 2,547.00 2,542.00 2,538.00 2,541.00 2,580.00 2,679.00 2,748.00 2,787.00
Gross Margin
74.80% 76.32% 73.17% 70.63% 72.02% 67.20% 69.29% 68.06% 67.82% 64.75%
EBIT Margin
34.01% 31.51% 4.91% 30.84% 27.10% 13.36% 20.26% 21.12% 16.94% 13.81%
Net Profit Margin
28.08% 26.68% 0.61% 24.49% 26.79% 17.02% 25.16% 14.71% 5.97% 9.85%
Free Cash Flow Margin
19.01% 28.20% 15.21% 24.81% 17.81% 7.68% 14.10% 19.64% 11.37% 22.01%
EBITDA
27,945.00 24,720.00 6,826.00 22,191.00 16,413.00 9,034.00 11,236.00 13,450.00 11,473.00 10,970.00
EBIT
22,107.00 20,221.00 2,954.00 18,282.00 13,199.00 5,548.00 7,926.00 8,931.00 6,797.00 5,499.00

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026